Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics

Alternative splicing (AS) is a critical post-transcriptional regulatory mechanism used by more than 95% of transcribed human genes and responsible for structural transcript variation and proteome diversity. In the past decade, genome-wide transcriptome sequencing has revealed that AS is tightly regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessa, Cláudia, Matos, Paulo, Jordan, Peter, Gonçalves, Vânia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729450/
https://www.ncbi.nlm.nih.gov/pubmed/33261131
http://dx.doi.org/10.3390/ijms21239032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729450/
https://www.ncbi.nlm.nih.gov/pubmed/33261131
http://dx.doi.org/10.3390/ijms21239032

Ejemplares similares